{"id":"https://openalex.org/W176949164","doi":"https://doi.org/10.2165/11531920-000000000-00000","title":"Cetuximab-Associated Elongation of the Eyelashes","display_name":"Cetuximab-Associated Elongation of the Eyelashes","publication_year":2010,"publication_date":"2010-08-21","ids":{"openalex":"https://openalex.org/W176949164","doi":"https://doi.org/10.2165/11531920-000000000-00000","mag":"176949164","pmid":"https://pubmed.ncbi.nlm.nih.gov/20726623"},"language":"en","primary_location":{"id":"doi:10.2165/11531920-000000000-00000","doi":"https://doi.org/10.2165/11531920-000000000-00000","is_oa":false,"landing_page_url":"https://doi.org/10.2165/11531920-000000000-00000","pdf_url":null,"source":{"id":"https://openalex.org/S71020152","display_name":"American Journal of Clinical Dermatology","issn_l":"1175-0561","issn":["1175-0561","1179-1888"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103181930","display_name":"Philip R Cohen","orcid":"https://orcid.org/0000-0003-4772-2898","observed_orcids":["https://orcid.org/0000-0003-4772-2898"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I44461941","display_name":"University of Houston","ror":"https://ror.org/048sx0r50","country_code":"US","type":"education","lineage":["https://openalex.org/I44461941"]},{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Philip R. Cohen","raw_affiliation_strings":["The University of Houston Health Center, University of Houston, Texas, USA. mitehead@aol.com","The University of Texas MD Anderson Cancer Center","University of Houston","University of Texas-Houston Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Houston Health Center, University of Houston, Texas, USA. mitehead@aol.com","institution_ids":["https://openalex.org/I44461941"]},{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"University of Houston","institution_ids":["https://openalex.org/I44461941"]},{"raw_affiliation_string":"University of Texas-Houston Medical School","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110079817","display_name":"Susan Marie Escudier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan M. Escudier","raw_affiliation_strings":["Texas Oncology P.A., Houston, Texas, USA","Texas Oncology, P.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Oncology P.A., Houston, Texas, USA","institution_ids":["https://openalex.org/I2800124591"]},{"raw_affiliation_string":"Texas Oncology, P.A","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Razelle Kurzrock","raw_affiliation_strings":["Department of Clinical Therapeutics (a Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA","THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Therapeutics (a Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5103181930"],"corresponding_institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I44461941","https://openalex.org/I919571938"],"apc_list":{"value":5590,"currency":"USD","value_usd":5590},"apc_paid":null,"fwci":3.8674,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.92132599,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"12","issue":"1","first_page":"63","last_page":"67"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9570000171661377},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.9300000071525574},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7210000157356262},{"id":"https://openalex.org/keywords/metastatic-rectal-carcinoma","display_name":"metastatic rectal carcinoma","score":0.9539999961853027},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.859000027179718},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/panitumumab","display_name":"panitumumab","score":0.9940000176429749}],"concepts":[{"id":"https://openalex.org/C2779884382","wikidata":"https://www.wikidata.org/wiki/Q160108","display_name":"Eyelash","level":2,"score":0.8833560943603516},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8680592775344849},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.8629847764968872},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.8469911217689514},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.7825607657432556},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.6485830545425415},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5693016052246094},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5049014687538147},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4970891773700714},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4882200062274933},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.4570688009262085},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.441710889339447},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4308796525001526},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.42040717601776123},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30986741185188293},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005140","descriptor_name":"Eyelashes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005140","descriptor_name":"Eyelashes","qualifier_ui":"Q000254","qualifier_name":"growth & development","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012004","descriptor_name":"Rectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012004","descriptor_name":"Rectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2165/11531920-000000000-00000","doi":"https://doi.org/10.2165/11531920-000000000-00000","is_oa":false,"landing_page_url":"https://doi.org/10.2165/11531920-000000000-00000","pdf_url":null,"source":{"id":"https://openalex.org/S71020152","display_name":"American Journal of Clinical Dermatology","issn_l":"1175-0561","issn":["1175-0561","1179-1888"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Dermatology","raw_type":"journal-article"},{"id":"pmid:20726623","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20726623","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of clinical dermatology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W73046920","https://openalex.org/W1505476460","https://openalex.org/W1972119499","https://openalex.org/W1973060721","https://openalex.org/W1976768579","https://openalex.org/W1980302506","https://openalex.org/W1991915991","https://openalex.org/W1993977910","https://openalex.org/W1998085563","https://openalex.org/W2004993339","https://openalex.org/W2007540203","https://openalex.org/W2011513069","https://openalex.org/W2016506204","https://openalex.org/W2038589074","https://openalex.org/W2039979010","https://openalex.org/W2047792959","https://openalex.org/W2049399926","https://openalex.org/W2050136767","https://openalex.org/W2052100628","https://openalex.org/W2054480025","https://openalex.org/W2058992264","https://openalex.org/W2061238329","https://openalex.org/W2065621410","https://openalex.org/W2069495454","https://openalex.org/W2075285275","https://openalex.org/W2086727820","https://openalex.org/W2090359261","https://openalex.org/W2091733433","https://openalex.org/W2092542306","https://openalex.org/W2096322927","https://openalex.org/W2097584581","https://openalex.org/W2118011560","https://openalex.org/W2121275619","https://openalex.org/W2122659547","https://openalex.org/W2148011843","https://openalex.org/W2158024758","https://openalex.org/W2163592822","https://openalex.org/W2165164569","https://openalex.org/W2167313634","https://openalex.org/W2170525810","https://openalex.org/W2192280218","https://openalex.org/W2311575084","https://openalex.org/W2428442425","https://openalex.org/W2434970353","https://openalex.org/W2460495142","https://openalex.org/W4230679792","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2408152862","https://openalex.org/W2079016979","https://openalex.org/W2139530335","https://openalex.org/W2317657428","https://openalex.org/W2050396366","https://openalex.org/W2053635813","https://openalex.org/W2122216528","https://openalex.org/W4391454984","https://openalex.org/W4226076947","https://openalex.org/W7095803129"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}